Physitrack PLC (STO:PTRK)
Sweden · Delayed Price · Currency is SEK 8.76
-0.32 (-3.52%)
Aug 12, 2026, 5:17 PM CET
Physitrack Revenue
Physitrack had revenue of 3.44M EUR in the quarter ending June 30, 2026, with 7.68% growth. This brings the company's revenue in the last twelve months to 9.99M, down -25.33% year-over-year. In the year 2025, Physitrack had annual revenue of 13.52M, down -2.50%.
Revenue (ttm)
9.99M EUR
Revenue Growth
-25.33%
P/S Ratio
0.93
Revenue / Employee
302.84K EUR
Employees
33
Market Cap
142.44M SEK
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.52M | -346.68K | -2.50% |
| Dec 31, 2024 | 13.87M | -880.28K | -5.97% |
| Dec 31, 2023 | 14.75M | 2.24M | 17.87% |
| Dec 31, 2022 | 12.51M | 4.52M | 56.56% |
| Dec 31, 2021 | 7.99M | 4.94M | 161.64% |
| Nov 30, 2020 | 3.05M | 1.85M | 154.21% |
| Nov 30, 2019 | 1.20M | 344.39K | 40.19% |
| Nov 30, 2018 | 857.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.24B |
| Swedish Orphan Biovitrum AB | 30.62B |
| Sectra AB | 3.65B |
| Camurus AB | 2.27B |
| Boule Diagnostics AB | 461.29M |
| Nanologica AB | 31.83M |
| iZafe Group AB | 7.09M |
| Xintela AB | 2.59M |
Physitrack News
- 22 days ago - Physitrack Earnings Call Transcript: Q2 2026 - Transcripts
- 22 days ago - Physitrack Quarterly report: Q2 2026 - Filings
- 22 days ago - Physitrack Slides: Q2 2026 - Filings
- 3 months ago - Physitrack Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - Physitrack Quarterly report: Q1 2026 - Filings
- 3 months ago - Physitrack Slides: Q1 2026 - Filings
- 5 months ago - Physitrack Earnings Call Transcript: Q4 2025 - Transcripts
- 5 months ago - Physitrack Annual report: Q4 2025 - Filings